Lol. Yes, I'm just as guilty but I know when I have been an...

Lol. Yes, I'm just as guilty but I know when I have been an idiot. I think the company have done alright if this capital raise is successful. I assume the company looked at the trajectory of the upcoming results and concluded that they would be better going early with a pump on the CF33 "cure for all forms of cancer". They've got to do what they have got to do. They don't have control over the results and they've got to keep this thing going. Also, the upcoming results may actually be quite good, but we have seen many times the share price go down on biotechs after moderately good results.

My reading of the tea leaves is they are just setting up to cover all bases going forward, there will be a share consolidation next (imo). It puts them in a better position to negotiate on good results and to weather the storm of bad results. If all else fails they will have the resources to get to the next wave as CF33 results start coming in.